Nina Barnett,Orla Kelly
Nina Barnett
Deprescribing can feel risky: prescribers need to consider the consequence of stopping a medication medicolegally, particularly where there may be a guideline or accepted practice that suggests its use. This review aims to provide reassuran...
Overview of current and future research and clinical directions for drug discontinuation: psychological, traditional and professional obstacles to deprescribing [0.03%]
药物停用的当前和未来研究及临床方向综述：减药障碍的心理学、传统和专业性因素概述
Doron Garfinkel;IGRIMUP
Doron Garfinkel;IGRIMUP
The vicious circle of age-related diseases, many experts and guidelines/drugs fuels the 21st century iatrogenic epidemic of inappropriate medication use and polypharmacy. There are no evidence-based medicine (EBM) 'guidelines' for treating ...
Alan J Poots,Barry Jubraj,Nina L Barnett
Alan J Poots
Alpana Mair,Fernando Fernandez-Llimos;SIMPATHY Consortium
Alpana Mair
Nina Barnett,Barry Jubraj
Nina Barnett
Registration and abstract submissions now open for EAHP Congress 2017 [0.03%]
EAHP大会2017已经开始接受注册和摘要提交
Richard Price
Richard Price
Setting up a homecare service for zoledronic acid treatment of osteoporosis [0.03%]
居家注射唑来磷酸治疗骨质疏松症的照护服务之建立
See Mun Wong,Sarah Pacey,Opinder Sahota
See Mun Wong
Increasingly, patients are able to receive parenteral medicines at home rather than in the hospital setting. We describe our approach to setting up a new intravenous zoledronic acid homecare service for patients with osteoporosis. Initial e...
A review of the use of mexiletine in patients with myotonic dystrophy and non-dystrophic myotonia [0.03%]
美西律在肌迟缓性营养不良和非营养不良性肌强直患者中的应用评估综述
Simon D&#x;Mello,Ling Shum
Simon D&#x;Mello
Introduction: Myotonia is found in a number of muscle diseases, including myotonic dystrophy and non-dystrophic myotonia. The resulting symptoms of myotonia can interfere with daily activities such as walking or climbing ...